Engitix
Drug discovery company using human extracellular matrix models to develop therapies for fibrosis and solid tumours.
engitix.com ↗Why it's here
Raised £18.6M (about €21M) in a Series A follow-on in January 2026, above the $20M equity bar within 24 months.
source: funding.tech.eu- Focus
- ECM Drug Discovery
- Founded
- 2016
- Latest round
- Series A extension, £18.6M, Jan 2026
- London office
- 4th Floor, The WestWorks, 195 Wood Lane, Hammersmith and Fulham W12 7FQsource: engitix.com
- London presence
- HQsource: bioworld.com
- Investors
- Netherton Investmentssource: funding.tech.eu
- Recognised on
- Sifted 100 UK & Ireland 2024, #70source: content.sifted.eu
- Nearest station
- White City, 311 m
- Hiring
- 4 open roles in London ↗Public job board, checked 9 Oct 2026
- Visas
- Licensed visa sponsor, listed as Engitix Limitedsource: gov.uk
Verified 6 Oct 2026. How we verify · Suggest a fix
For Engitix
Work here? Show you're on the map. Add the badge to your site or README, or share the listing.
<a href="https://londonmempool.co.uk/c/engitix"><img src="https://londonmempool.co.uk/badge/engitix.svg" alt="Engitix is listed on London Mempool" width="361" height="28"></a>
Add ?theme=light to the image URL for light backgrounds.